diabetic
Troglitazone exerts an antihyperglycemic activity in a       dose-dependent manner between 200 and 600 mg/day in type 2 diabetic patients       treated with diet alone, sulfonylureas, or insulin.
Troglitazone exerts an antihyperglycemic activity in a       dose-dependent manner between 200 and 600 mg/day in type 2  @SUBJECT$  @PREDICAT$  @OBJECT$        treated with diet alone, sulfonylureas, or insulin.